Kahn-Sagol-Maccabi (KSM), the research and innovation center of Israel’s Maccabi Healthcare Services, and Genetika+, a pioneer in personalized medicine for the brain, are partnering to advance the development of tools to personalize depression treatment using Artificial Intelligence (AI) and advanced analytics.
The collaboration between Genetika+ and KSM is focused on conducting large-scale state-of-the-art analysis on extensive data from patients suffering from depression in order to further develop and validate Genetika+’s AI-based algorithms that help physicians treat patients with depression based on their individual characteristics.
Depression currently affects an estimated 300 million people worldwide. While many depression medications exist on the market, individual responses vary significantly, and many people do not respond to drugs even after trying multiple medications. Today physicians generally rely on a trial-and-error approach to treat patients, leading to continued suffering and extensive side effects from the various drugs.
Combining AI solutions with advanced analytics and rich data, such as patient medical history, co-morbidities, and polypharmacy, KSM and Genetika+ aim to optimize the treatment process so that physicians can treat patients more efficiently and effectively.
“We are facing a surging mental health crisis around the world, across all ages, from children to young adults and through the elderly, alongside the rise of our technological advances and dependence in COVID times,” said Dr. Tal Patalon, head of KSM. “We must improve our early detection abilities, as well as our personalized treatment for mental health challenges while providing better comprehensive biopsychosocial support and treatment.”
“We are particularly excited about this collaboration and the ability to use the Maccabi data to support the optimization of treatment in depression,” said Dr. Daphna Laifenfeld, co-founder and Chief Strategy Officer of Genetika+. “The depth and richness of the Maccabi database are unique assets that will help us bring robust and validated solutions to the clinic, to support physicians and bring relief and quality of life to patients.”
Source: https://www.ksminnovation.com/
Genetika+ and KSM Collaboration Focuses on Developing AI Tools to Personalize Depression Treatment & Latest News Update
Genetika+ and KSM Collaboration Focuses on Developing AI Tools to Personalize Depression Treatment & More Live News
All this news that I have made and shared for you people, you will like it very much and in it we keep bringing topics for you people like every time so that you keep getting news information like trending topics and you It is our goal to be able to get
all kinds of news without going through us so that we can reach you the latest and best news for free so that you can move ahead further by getting the information of that news together with you. Later on, we will continue
to give information about more today world news update types of latest news through posts on our website so that you always keep moving forward in that news and whatever kind of information will be there, it will definitely be conveyed to you people.
Genetika+ and KSM Collaboration Focuses on Developing AI Tools to Personalize Depression Treatment & More News Today
All this news that I have brought up to you or will be the most different and best news that you people are not going to get anywhere, along with the information Trending News, Breaking News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, World News of this made available to all of you so that you are always connected with the news, stay ahead in the matter and keep getting today news all types of news for free till today so that you can get the news by getting it. Always take two steps forward
Credit Goes To News Website – This Original Content Owner News Website . This Is Not My Content So If You Want To Read Original Content You Can Follow Below Links